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Abstract: Objective: The aim of this study was to analyse the prevalence of 
pelvic floor disorders and to describe health-related quality of 
life(HRQoL)among older women. We also compared participants' HRQoL with the 
age-matched general female population and analysed factors associated with 
HRQoL.Study design: This is a population-based study of a cohort of women 
born in 1948 and in 1950 (n = 143) which is also part of the Women's 
Gynaecological Health study in Lieto, Finland. Methods: The data were 
collected by questionnaires which pertained to socio-demographics, health-
related variables, pelvic floor disorders and HRQoL (15D). Linear model was 
conducted to estimate a model of factors that associated with HRQoL. 
Results: The prevalence of urinary incontinence, faecal incontinence and 
pelvic organ prolapse was 50%, 13% and 12%, respectively. The overall HRQoL 
score of the study cohort is broadly similar to that of the agematched 
general Finnish female population (mean±SD15D scores 0.905±0.084 vs 
0.912±0.077). Higher number of medications was the most important 
explanatory factor for lower HRQoL. 
Conclusion: Urinary incontinence was common; however, the impact on HRQoL 
was minor. The overall HRQoL score of the study cohort was broadly similar 
to that of age-matched general female population. Women who used a higher 
number of medications had lower HRQoL compared to women who used fewer 
medications. 
 
Keywords: older women, pelvic floor disorders, health-related quality of 
life 
1. Introduction  
 
In most developed countries, an increase in the number and proportion of people over 65 years is 
expected in the coming decades. Older women make up a significant proportion of the world’s 
population and their numbers are growing. (WHO 2015.) This demographic trend is associated with 
a higher incidence of pelvic floor disorders (PFDs), i.e., urinary incontinence (UI), faecal 
incontinence (FI) and pelvic organ prolapse (POP) (Nygaard & Barber 2008; Wu et al. 2014; Costa 
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et al. 2018). Despite their growing prevalence, PFDs remain undertreated and are not well 
understood by ageing women (Hobdy et al. 2018).  
 
Previous studies have identified that PFDs reduce older women’s health-related quality of life 
(HRQoL), with physical, psychological, sexual and social implications (Milsom et al. 2017, 
Bardsley 2018, Knut et al. 2018). A recent study by Knut and colleagues (2018) demonstrated that 
even mild urinary leakage reduces the quality of life significantly whereas a subsequent increase in 
the degree of incontinence has only minimal additional effect. It is important to gain more 
understanding of how PFDs affect the HRQoL of older women.  
 
PFDs are common and affect at least one in every four women (Dieter et al. 2015). In a review of 
30 studies comprising a total of 83,000 women from 15 countries, the mean prevalence of UI was 
30% (range 5–71%), that of POP 20% (range 3–56%), and that of FI 7% (range 5–41%) (Walker & 
Gunasekera 2010). The prevalence of one or more PFDs has been reported to be 46%, and many 
women have a combination of the conditions (Milsom et al. 2017). 
 
UI is the most common PFD (Nygaard & Barber 2008; Costa et al. 2018, Milsom et al. 2018). UI is 
a common condition worldwide and across different cultures, often increasing as women age (Sung 
& Hampton 2009; Kwon et al. 2010). Markland and colleagues (2008) reported that in community-
dwelling older women (aged 65 and over), the prevalence of UI was 27%. UI, defined by the 
International Continence Society as any involuntary loss of urine, can be classified into stress 
incontinence, urge incontinence and mixed incontinence (Haylen et al. 2010). In older women, urge 
and mixed incontinence is more common than stress incontinence (Sung & Hampton 2009).  
 
PFDs remain hidden because of the “culture of silence” surrounding women’s lives (Susila & Roy 
2014, Hobdy et al. 2018). Most women with these symptoms will never seek support and care for 
these debilitating symptoms (Basu & Duckett 2009, Sung & Hampton 2009). However, PFDs are 
often treatable. There are behavioural and pharmacologic treatments, devices and surgical 
interventions which can help ageing women as well. A systematic Cochrane review shows, for 
example, that high-quality evidence was found favouring the use of pelvic floor muscle training 
among women with urinary incontinence (Costa et al. 2018). In clinical practice, it is therefore 
important to recognise PFDs that may impact older women’s HRQoL (Hobdy et al. 2018). HRQoL 
denotes an individual’s perception of the impact of changes in their physical and emotional health 
status on their functioning and well-being (Sintonen 2001).  
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The aim of this study was to analyse the prevalence of pelvic floor disorders and to describe health-
related quality of life (HRQoL) among older women born in 1948 and 1950. We also compared 
participants’ HRQoL with that of a representative sample of the age-matched general Finnish 
female population and analysed the association of socio-demographic, health-related variables and 
PDFs with HRQoL.  
 
2. Material and methods 
 
2.1 Design 
A population-based study of the cohort of women born in the years 1948 and 1950. This study is 
part of the Women’s Gynaecological Health study in Lieto, Finland. This study started in 2016 with 
the aim to evaluate gynaecological health and health-related factors in older women living in the 
community in Lieto, Finland. In the future, the aim is to follow up these cohorts as they age.  
 
2.2.Participants and data collection 
All the home-dwelling women in the Lieto area in Southwest Finland born in 1948 (N = 114, n = 
67) and in 1950 (N = 128, n = 76) were originally considered eligible for the study. Lieto is a rural 
district in southwestern Finland. It has a population of about 20,000. All samples were 
systematically obtained, based on year of birth, from the Finnish Population register.  
 
The data were collected in 2016 using questionnaires and clinical examinations. First, we sent an 
informed consent to the participants (N = 242) by post, which they signed and returned to the 
researchers.  After this, the participants were sent questionnaires and an invitation for an 
appointment at the gynaecology clinic. The non-respondents were sent a reminder letter. 143 (59%) 
returned the postal questionnaires and participated in the clinical examinations (Figure 1). The 
clinical examinations by the study nurse and gynaecologist were conducted at the University 
Hospital in Turku, Finland. The study nurse went through the questionnaires with the participants, 
making some additional notes, if necessary. In this study, we report data from the questionnaires.   
 
 
 
 
All women in Lieto 
born in 1948 
N = 114 
All women in Lieto 
born in 1950 
N = 128 
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Figure 1. Study population of Women’s Gynaecological Health study in Lieto, Finland. 
 
2.3.Questionnaires and data analysis    
Explanatory variables 
The socio-demographic factors used as explanatory variables were living status and educational and 
occupational background. Education was categorized according to whether secondary school or 
more had been attended or not. 
 
The health-related factors that were addressed in this analysis included parity, gynaecological 
surgery, BMI and the number of regular medications. Body mass index (BMI) was classified as <24 
kg/m2 (underweight), 24–29 kg/m2 (normal weight) and >29 kg/m2 (overweight) (Duodecim 
2015). 
 
PFDs as explanatory variables were measured by urinary incontinence (UI) (yes/no), type of UI, 
impact of UI, faecal incontinence (yes/no) and pelvic organ prolapse (yes/no). Type of UI was 
evaluated with Urogenital Distress Inventory (UDI-6, short version) and the impact of UI was 
evaluated with visual analogue scale (VAS 0–10) (Kauppila et al. 1982; Uebersax et al. 1995; 
Stach-Lempinen et al. 2001).  
 
 
 
 
Dependent variables 
HRQoL was the dependent variable and it was measured with a generic HRQoL instrument (15D). 
The 15D is a 15-dimensional, standardized HRQoL instrument that can be used both as a profile 
and single index score measure. The 15D instrument includes the following dimensions: mobility, 
Postal questionnaires 
and clinical 
examinations, 
respondents, n = 76 
(59%) 
Respondents    
n = 143 (59%) 
Postal questionnaires 
and clinical 
examinations, 
respondents, n = 67 
(59%) 
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vision, hearing, breathing, sleeping, eating, speech, excretion, usual activities, mental function, 
discomfort and symptoms, depression, distress, vitality and sexual activity, each of them with 5 
possible levels. The single index score (15D score), representing the overall HRQoL on a 0-1 scale 
(1=full health, 0=being dead) and the dimension level values, reflecting the goodness of the levels 
relative to no problems on the dimension (=1) and to being dead (=0), are calculated from the 
questionnaire by using a set of population-based preference or utility weights. Mean dimension 
level values are used to draw 15D profiles for groups. The 15D has shown good psychometric 
properties in a number of earlier studies. (Sintonen 2001.) The minimum clinically important 
change or difference in the 15D score has been estimated to be ±0.015 on the basis that people can 
on average feel such a difference. (Alanne et al. 2015) 
 
The 15D data for the general population came from the National Health 2011 Survey representing 
the Finnish population aged 18 and over. For this analysis those women were selected, who were of 
the same age as the cohorts (n=125). (Koskinen S, Lundqvist A, Ristiluoma N (eds.) Health, 
functional capacity and welfare in Finland in 2011. National Institute for Health and Welfare 
(THL), Report 68/2012. Helsinki 2012. (http://urn.fi/URN:ISBN:978-952-245-769-1.) 
 
 
Data were described with frequencies (percentages), means (standard deviations) and medians, when 
appropriate. Independent samples t-test was used to test the statistical significance of the mean 
differences in the HRQoL and its dimensions between the study cohort and controls from the general 
population. The univariate associations of factors with HRQoL were analysed using Mann-Whitney 
U-test (factors with two categories) or Kruskal-Wallis test (factors with more than two categories). , 
and further pairwise comparisons were done using Steel-Dwass method. The factors significantly 
associated with HRQoL in univariate analysis were included in multivariable linear model to examine 
the explanatory variables independently associated with HRQoL. The residuals in linear model were 
normally distributed. All statistical analyses were performed with SAS System for Windows, version 
9.4 (SAS Institute Inc., Cary, NC, USA). P-values <0.05 were considered as statistically significant.  
 
 
2.4. Ethical considerations 
The study was approved by the Ethics Committee of the Hospital District of Southwest Finland 
(ETMK 133/1801/2014 or 18.11.2014§394, ClinicalTrials.gov registration ID: NCT02338726). In 
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accordance with the World Medical Association’s Declaration of Helsinki, this research followed 
commonly accepted ethical principles. Informed consent was obtained from all the participants, 
who were given assurances that their data would be treated confidentially. 
 
3. Results 
 
3.1. Participant characteristics  
 
Out of 242 women, 143 participated in this study. Most of them were retired (96%). More than half 
of the participants had secondary education or higher. 62% of participants had previous 
gynaecological surgery. Twenty per cent of the participants reported that they used five or more 
medications per day. The socio-demographic and health-related factors of the participants are 
shown in more details in Table 2.  
 
3.2.Prevalence of pelvic floor disorders 
These cohorts included 72 (50%) incontinent women; 46 (64%) of them had genuine stress 
incontinence, 16 (22%) had urge incontinence and 10 (14%) had a mixed condition. The mean of 
impact of UI was 3.08 (SD 2.57, VAS scale). Faecal incontinence was reported by 13% of the 
participants and pelvic organ prolapse by 12%. The PFDs of the participants are shown in more 
details in Table 2.   
 
3.3. Health-related quality of life in study cohorts compared with the general population 
There was no statistically significant and clinically important difference in the mean 15D score 
between the study cohorts and age-matched general Finnish female population. When single 
dimensions were compared, study cohorts had significantly impaired HRQoL on four dimensions, 
i.e., sleeping (p = 0.012), depression (p = 0.011), distress (p = 0.001), and discomfort and symptoms 
(p = 0.035). The study cohorts reported a better score in mental function (p = 0.001). (Table 1, 
Figure 2) 
 
 
 
 
Table 1. Mean (SD) health-related quality of life (15D) scores and profiles of the cohorts of this 
study (n = 143) and age-matched general Finnish female population control cohort (n = 125). 
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Cohorts 
Mean (SD) 
n = 143 
General 
population 
Mean (SD) 
n = 125 
p-value Mean Difference 
(95% CI) 
15D score .905 (.084) .912 (.077) .469 0.007 (0.012–0.027) 
Mobility .938 (.144) .928 (.142) .588 0.009 (0.044-0.025) 
Vision .959 (.118) .948 (.173) .521 0.012 (0.047-0.024) 
Hearing .948 (.126) .964 (.088) .224 0.016 (0.009-0.042) 
Breathing .908 (.170) .910 (.160) .947 0.013 (0.038-0.041) 
Sleeping .776 (.183)  .830 (.1510) .012 0.053 (0.012-0.095) 
Eating .991 (.063) 1.000 (.00) .098 0.009 (0.001-0.020) 
Speech .985 (.064) .982 (.088) .719 0.003 (0.021-0.016)  
Excretion .822 (.209) .863 (.197) .101 0.041 (0.008-0.089) 
Usual activities .941 (.149) .926 (.146) .423 0.014 (0.050-0.021) 
Mental function .929 (.151) .861 (.178) .001 0.068 (0.108-0.028) 
Discomfort and symptoms .754 (.205) .806 (.193) .035 0.051 (0.004-0.099) 
Depression .899 (.139) .939 (.116) .011 0.040 (0.009-0.070) 
Distress .894 (.155) .948 (.117) .001 0.054 (0.021 – 0.087) 
Vitality .885 (.146) .910 (.121) .135 0.024 (0.008-0.057) 
Sexual activity .888 (.202) .927 (.166) .079 0.040 (0.004-0,084) 
 
 
 
Figure 2. Mean health-related quality of life (15D) scores and profiles of the cohorts of this study 
(n = 143) and age-matched general Finnish female population control cohort (n = 125). 
 
 
3.4.Factors associated with health-related quality of life (15D) 
In univariate analysis, the factors that were significantly associated with HRQoL were BMI, 
number of medications and faecal incontinence. The median 15D score was significantly lower in 
women who were overweight (BMI >29 kg/m2) compared to those who were normal weight (24–
29 kg/m2) (p = 0.039) or underweight (<24 kg/m2) (p = 0.009). The median 15D score was 
significantly lower in women who used 5 or more medications compared to those who used 1–4 
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medications (p = 0.012) and non-medication users (p < 0.001), and also between women who used 
1-4 medications and non-medication users (p < 0.001). The median 15D score was significantly 
lower in women who suffered from faecal incontinence compared to those who did not (p = 0.014). 
(Table 2) 
 
Table 2. Associations of explanatory variables with HRQoL in study cohorts. 
*Mann-Whitney U-test 
#Kruskal-Wallis test; pairwise comparisons with Steel-Dwass method for BMI >29 kg/m2 vs 24-29 
kg/m2 (p=0.039) and >29 kg/m2 vs <24 kg/m2 (p=0.009) and for number of regular medicine 0 vs 1-
4 (p<0.001), 0 vs 5 or more (p<0.001) and 1-4 vs 5 or more (p=0.012).  
 
In multivariable analysis, BMI, number of medications and faecal incontinence were included as 
explanatory variables in linear model. The number of regular medications (p < 0.001) remained as a 
statistically significant explanatory factor for lower HRQoL, whereas BMI (p = 0.414) and FI (p = 
0.140) did not remain significant (p = 0.140). A higher number of medications was a statistically 
significant explanatory factors for lower HRQoL. (Table 3)  
 
Explanatory variables Description of variable  N (%) Mean (SD)/ 
Median 15D 
score 
p-value* 
Socio-demographic factors     
 Living status Alone 30 (21) .901(.081)/ .923  
 Living together 113 (79 .906 (.086)/ .929 0.704* 
 Educational status Primary or less 58 (40) .900 (.077)/ .910 0.247* 
 Secondary or more 85 (60) .908 (.089)/ .936 
 Occupational status Employed 6 (4) .905 (.086)/ .929 0.478* 
 Retired 137 (96) .906 (.037)/ .902 
Health-related factors     
 Parity 0-1 35 (25) .930 (.059)/ .945 0.118# 
 2-3 99 (69) .896 (.091)/ .923 
 4-5 9 (6) .904 (.085)/ .929 
 Gynaecological surgery No 55 (38) .909 (.070)/ .926 0.992* 
 Yes 88 (62) .902 (.093)/ .929 
  BMI <24 kg/m2 47 (33) .926 (.059)/ .940 0.009# 
 24–29 kg/m2 60 (42) .913 (.076)/ .932 
 >29 kg/m2 36 (25) .863 (.110)/ .889 
Number of regular medications 0 39 (25) .955 (.041)/ .962  
  1-4 79 (55) .903 (.067)/ .912 <0.001# 
 5 or more 25 (20) .830 (.122)/ .851 
Pelvic floor disorders      
 Urinary incontinence No 71 (50) .913 (.079)/ .936 0.193 
 Yes 72 (50) .896 (.089)/ .923 
 Faecal incontinence No  125 (87) .910 (.084)/ .936 0.014* 
 Yes 18 (13) .870 (.081)/ .881 
 Pelvic organ prolapse No 126 (88) .906 (.085)/ .932 0.396* 
 Yes 17 (12) .894 (.077)/ .896 
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Table 3. Associations of explanatory variables with HRQoL at study cohorts in multivariable linear 
model. 
 Adjusted mean (SE) p-value 
BMI   
 <24 0.894 (0.014) 0.414 
 24-29 0.889 (0.013) 
 >29 0.871 (0.015) 
Use of medication   
 0 0.936 (0.016) <0.001* 
 1-4 0.893 (0.011) 
 5 or more 0.825 (0.017) 
Faecal incontinence   
 No 0.899 (0.007) 0.140 
 Yes 0.870 (0.018) 
* Pairwise comparisons with Tukey’s method: 0 vs 1-4 (p=0.015), 0 vs 5+ (p<0.001) and 1-4 vs 5+ (p<0.001). 
 
4. Discussion 
 
4.1. Findings 
 
In this study, we analysed the prevalence of PFDs and described HRQoL among older women born 
in 1948 and 1950. We also compared participants’ HRQoL with general Finnish female population 
and analysed the association of socio-demographics, health-related variables and PDFs with 
HRQoL. This study is part of the population-based cohort study Women’s Gynaecological Health in 
Lieto, Finland. A similar study charting gynaecological problems in older women has not 
previously been conducted in the Finnish population.  
 
This study indicates that UI was common among older women, with a prevalence of 50%. 
However, the impact of UI was quite minor, VAS mean 3.08, SD 2.57 (see Stach-Lempinen et al. 
2001). Of the participants, 13% reported faecal incontinence and 12% pelvic organ prolapse. 
Previous studies suggesting that the prevalence of urinary incontinence in community-dwelling 
older women was 27% (Markland et al. 2008). The prevalence of urinary incontinence varies a lot 
between studies. The factors contributing to this may include how incontinence has been 
investigated in different studies. The incontinence symptoms may also fluctuate, and spontaneous 
recovery occurs as well. It is stated that most women with these symptoms will never seek support 
and care for these symptoms (Basu & Duckett 2009, Sung & Hampton 2009). It has been found that 
PFDs remain hidden because of the “culture of silence” surrounding women’s lives (Susila & Roy 
2014, Hobdy et al. 2018). In health care, assessment of older women’s overall health status is 
important, as PFDs are relatively common and there are various methods to prevent and treat them 
AC
CE
PT
ED
 M
AN
US
CR
IPT
   10 
  
(Krhut et al. 2017). In general, it is important to bear in mind that in older people, good functional 
ability also promotes continence and maintenance of good pelvic muscle tone (Gibson & Wagg 
2014, Jung et al. 2015).  
 
At a clinical level, incontinence may cause embarrassment and reluctance to leave the home, 
leading to social isolation and decreased activity levels among older women. It has been found that 
compared with younger people, older adults are less likely to mention incontinence to their health 
care providers, reflecting a societal view that incontinence is a normal part of ageing (Smith & Shah 
2018). Many individuals do not seek help due to the taboo and stigmatizing nature of the condition 
(Bardsley 2018).  With age, the prevalence of gynaecological problems increases (Bardsley 2018), 
but help and treatment is available. Healthcare professionals should take every opportunity to ask 
about PFDs so that symptomatic relief and treatment interventions can be initiated (Bardsley 2018). 
It is important to identify women who would benefit from different interventions (Smith & Shah 
2018). Even minor interventions or guidance can significantly affect women’s gynaecological 
health in the upcoming years. 
 
In the present study, we found that there was no statistically significant difference in the mean (SD) 
15D score between the study cohorts and an age-matched general female population. When 
comparing single dimensions, study cohorts had a better score in mental function than the general 
population. On the other hand, the study cohorts had significantly impaired HRQoL in sleeping, 
depression, distress and discomfort and symptoms. HRQoL is a key aspect of aging (Avis et al. 
2018). In older women, efforts aimed at supporting quality of life should focus on the factors 
identified in this study: problems with sleep, depression and distress, and discomfort and symptoms. 
 
Our univariate analyses showed that faecal incontinence, overweight (>29 kg/m2) and a higher 
number of medications were statistically significant explanatory factors for lower HRQoL. Previous 
studies have stated that PFDs reduce older women’s HRQoL (Stach-Lempinen et al. 2004, Milsom 
et al. 2017, Bardsley 2018, Knut et al. 2018). In this study, faecal incontinence was the only PFD 
that impaired respondents’ quality of life. As is known, faecal incontinence affects the ability to live 
a normal life and has huge emotional impact on people. It may also lead to social isolation and 
decreased activity levels among older women. (e.g. Smith & Shah 2018.) Health care professionals 
should be more aware of faecal incontinence and its detrimental effects on the quality of life. They 
should encourage women to discuss their problems because women who suffer from faecal 
incontinence should be identified and offered help in a timely manner.   
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In multivariable analyses, we found that a higher number of medications was a statistically 
significant explanatory factors for lower HRQoL. In gerontological studies, it has been shown that 
medication use among older people has increased in the last few decades (Hovstadius et al. 2010). 
In this study, one in every four subjects used more than five medications daily. The large number of 
medications indicates accumulation of health problems in some subjects, which may be reflected in 
the results of the study. Further studies are needed to clarify this issue. Our results provide new 
information on where the focus should be in supporting the quality of life of an ageing female 
population to help them age successfully.   
 
4.2. Strengths and limitations 
 
The study has several limitations. It was conducted in a typical urban region of south-western 
Finland. The study sample was quite small (n=143), and nonresponse was comparatively high 
(response rate 59%), as is usually the case in epidemiological studies among older people. It is 
noteworthy that the respondents who perceived themselves as ill were more likely to withdraw their 
participation than those who saw themselves as healthy. It is possible that the older women who 
took part in the study were in better health than those who did not, which would obviously be 
reflected in the results. We used validated self-reporting questionnaires, which were well 
completed. The pelvic floor disorder items used in this study have been used earlier (Kauppila et al. 
1982; Uebersax et al. 1995; Stach-Lempinen et al. 2001). In addition, the health-related quality of 
life (15D) instrument used in this report is a standardized generic HRQoL instrument which has 
been used in earlier studies for a long time (Sintonen 2001). However, any generalizations from the 
results must be made with caution. Further studies should work with a larger sample and in different 
cultures to gain a fuller and more in-depth understanding of the issues concerned.  
 
5. Conclusions 
In conclusion, we observed that UI was common, but the harm it caused was minor.  In old age, the 
maintenance of overall functional capacity is a key element of good-quality life and has positive 
effects on gynaecological problems as well.  The overall HRQoL score of the study cohort was 
largely similar to that of general population of older women. Women who used a higher number of 
medications had lower HRQoL compared to women who used fewer medications. 
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